Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Drug discovery for the treatment of Human Immunodeficiency Virus disease field has been described by the both success and disappointments. The nucleoside reverse transcriptase inhibitors have been the significant improvement for the administration of the Acquired Immune Deficiency Disease Syndrome (AIDS) there has been notable lack of licensed compounds directed at sites other than reverse transcriptase. In the improvement of medications for the treatment of HIV contamination, various pressures can be distinguished which should be routed to allow successful drug development in the future.
Edelweiss Journal of AIDS journal is a Peer reviewed journal maintaining high standards of scientific excellence and its editorial board ensures a thorough review process.
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with HIV Drug discovery, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for HIV Drug discovery will appear here as matching content is published in Edelweiss Journal of AIDS. Readers can also browse the journal archive and current issue for connected research.
